Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823094 · ClinicalTrials.gov registry record
CTP Imaging of Lung Cancer
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 14
- Enrollment target
NCT01823094: Completed study, sponsored by University of California, Davis.
NCT01823094 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01823094 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Investigators hope to learn more about how to use computed tomography (CT) scans to measure blood flow in lung tumors and how it may change in response to treatment. This measurement technique is called computed tomography perfusion (CTP). CT scanners use X-rays to produce 3-dimensional images of the body. Currently, doctors determine the response to treatment by measuring the size of the tumor. Investigators are trying to find out if measuring the blood flow in the tumor is equal to or better than measuring the size of the tumor.
Primary Outcome
Yield is determined as the percentage of assessable CTP studies, relative to all performed studies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-06 |
What the finished NCT01823094 record still lists
NCT01823094 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01823094 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01823094 about?
NCT01823094 is a clinical study titled "CTP Imaging of Lung Cancer". Investigators hope to learn more about how to use computed tomography (CT) scans to measure blood flow in lung tumors and how it may change in response to treatment. This measurement technique is called computed tomography perfusion (CTP). CT scanners use X-rays to produce 3-dimensional images of th...
What is the current status of trial NCT01823094?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2013-03. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01823094?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia